Brazilian researchers observed an increase in production of endocannabinoid, a natural anti-inflammatory neurotransmitter, in COVID-19 patients given glucocorticoids. The discovery points to possibilities of novel treatments for various inflammatory and neurological diseases.
Olfactory tissue biopsies help researchers discover the mechanism responsible for COVID-19-related loss of smell, along with other long COVID symptoms.